Quest Diagnostics Incorporated · NYSE:DGX

Quest Diagnostics — Investor Day (November 2018)

15 slides from Quest Diagnostics's investor day presentation, Nov 29, 2018

  1. Slide 1: Data Analytics and Population Health Services

    Data Analytics and Population Health Services Dermot Shorten SVP, Strategy, M&A and Ventures Jay Wohlgemuth MD SVP, R&D, Employee Health and CMO

  2. Slide 2: Safe Harbor Disclosure

    SAFE HARBOR DISCLOSURE The statements in the following presentations that are not historical facts may be forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date that they are made and which reflect management’s cur

  3. Slide 3: We have made progress on our analytical solutions and are evolving towards increasing insight and value

    We have made progress on our analytical solutions and are evolving towards increasing insight and value Analytics-Driven HIGHER Services In Market In Development Risk Predictive Stratification Analytics VALUE CT Patient & Physician Lab Workflow Stewardship Analytics Outreach Pharma Health & Public P

  4. Slide 4: Quest Clinical Trials Connect helps speed drugs to market through better patient recruitment

    Quest Clinical Trials Connect helps speed drugs to market through better patient recruitment Quest keys Evolving clinical trial model Patient insights Direct to patient Patients Direct patient relationships Patient “Naïve” sites PSCs/ recruitment Traditional trials retail (Investigators + Direct rel

  5. Slide 5: When engaged early, we can locate potentially eligible patient populations for clinical trials

    When engaged early, we can locate potentially eligible patient populations for clinical trials by lab values and optimize site selection For a phase 3 cardiovascular trial that fell behind in … But only 4% of these patients lived near the trial's enrollment, we identified 180,000 potentially qualifi

  6. Slide 6: We add significant value by partnering up front

    We add significant value by partnering up front Multiple Myeloma Clinical Trial  Query Quest Diagnostics’ database for physicians  Compare Quest and Sponsor data The high level unique NPI numbers  Sponsor: ~300 US physicians  Quest: ~1,400 with ≥ 10 patients tested  ~1,100 additional physicians

  7. Slide 7: We are also leveraging our data to generate population health insights

    We are also leveraging our data to generate population health insights Public health Health plan Community outreach Nationwide HCV results Missouri HbA1C results Texas cotinine results Diabetes prevalence among tested population Pre-diabetes concentration in tested population (%) 7 Confidential | In

  8. Slide 8: Our data analytics and clinical solutions help payers, providers and employers deliver on population health

    Our data analytics and clinical solutions help payers, providers and employers deliver on the promise of population health Data and Clinical 001010010010011 solutions 1011101011101110 001010010010000 $ 0111001011001010 Data analytics: gaps in Consumer engagement care in a population Diabetes Kidney

  9. Slide 9: Blueprint for Wellness empowers population health for thousands of employers and millions of employees

    Blueprint for Wellness empowers population health for thousands of employers and millions of employees in the US Example: kidney failure prevention through BFW services Screen for Confirm Chronic Telemedicine Referral employees Kidney Disease consult with to PCP or at risk by retesting physician nep

  10. Slide 10: We can move the needle on Diabetes population health – $300B cost to our healthcare system

    We can move the needle on Diabetes population health – $300B cost to our healthcare system 001010010010011 1011101011101110 001010010010000 $ 0111001011001010 Data and Clinical Diabetes Data analytics: gaps in solutions Consumer engagement care in a population with solution • Lab testing: diabetes,

  11. Slide 11: We also can serve the critical need for management of chronic conditions

    We also can serve the critical need for management of chronic conditions that lead to the majority of healthcare costs Medicare chronic care management services • CMS benefit for care of people with 2 or more chronic conditions • Our services enable monthly community based monitoring and care on beh

  12. Slide 12: We have developed proprietary, consumer friendly self-collection technology to engage consumers at home

    We have developed proprietary, consumer friendly self-collection technology to engage consumers at home • Launched Blueprint for Athletes @Home 2017 • Offering Diabetes @Home services for health plans and health systems Q4 2018 • Annual health and Collect blood on device wellness and consumer Close

  13. Slide 13: We have strong delivery channels

    We have strong delivery channels Home / Mobile Care Retail / Community Telephonic Support Digital Health • Deliver risk assessment and • Deliver an innovative model • Chronic Care Management • Digital health capabilities both other services via network of care through the in-house and through partne

  14. Slide 14: Unique capabilities place Quest in the center of health care

    Unique capabilities place Quest in the center of health care Awareness Screening Diagnosis Intervention Engagement Management Patient intervention (Rx, Screening, Nutrition) 2 2 1 3 Screening Walk‐in/online appointment at retail At Risk site, PSC, or home visit Patient History / Biometrics 2 Identif

  15. Slide 15: Key takeaways

    Key takeaways  Our data analytics, provider and consumer connectivity empower clinical trials  Using our data analytics, we help payers, providers and employers deliver on the promise of population health  We have an unparalleled platform for consumer engagement with medical services in the home,

Quest Diagnostics — Investor Day (November 2018) on 6ix